Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stephen Y. Chan, Lewis J. Rubin. Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice. Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension: basic concepts and practical management Source: Eur Respir J 2008; 31: 236-237 Year: 2008 Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances? Source: Eur Respir J 2016; 47: 388-389 Year: 2016 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Pro: The current classification of pulmonary hypertension meets clinical practice Source: Virtual Congress 2021 – The current classification of pulmonary hypertension meets clinical practice Year: 2021 Contemporary issues in pulmonary hypertension Source: Eur Respir Rev 2010 19: 266-271 Year: 2010 Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018 Year: 2019 Contemporary pathology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice Source: Eur Respir J 2013; 42: 689-700 Year: 2013 Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018 Year: 2019 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018 Year: 2019 Reading list SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Hemodynamic and clinical relevance of “borderline pulmonary hypertension“ Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Interdisciplinary rehabilitation in pulmonary hypertension: can we learn from chronic obstructive pulmonary disease or heart failure? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Reading list SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Programme SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Right heart catheterisation: best practice and pitfalls in pulmonary hypertension Source: Eur Respir Rev 2015; 24: 642-652 Year: 2015